Immix Biopharma Income Statement (2020-2026) | IMMX

Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
0.06M0.03M0.01M0.63M0.61M0.70M2.26M1.32M2.21M2.11M3.10M3.25M2.22M4.45M1.37M1.98M3.97M4.58M5.73M5.98M
Selling, General & Administrative (Quarter)
0.18M0.32M0.59M0.70M0.95M0.84M1.53M1.20M1.51M2.42M2.28M2.34M2.48M2.95M3.61M2.71M2.75M3.08M5.17M4.82M
Operating Expenses (Quarter)
0.24M0.35M0.60M1.33M1.56M1.53M3.79M2.52M3.72M4.52M5.38M5.59M4.70M7.39M4.99M4.68M6.72M7.66M10.89M10.80M
Operating Income (Quarter)
-0.24M-0.35M-0.60M-1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M6.46M-5.59M-4.70M-7.39M-4.99M-4.68M-6.72M-7.66M-10.89M-10.80M
EBIT (Quarter)
-0.24M-0.35M-0.60M-1.33M-1.56M-1.53M-3.79M-2.52M-3.72M-4.52M6.46M-5.59M-4.70M-7.39M-4.99M-4.68M-6.72M-7.66M-10.89M-10.80M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.13M0.19M0.23M0.27M0.31M0.26M0.19M0.15M0.10M0.08M0.22M0.72M
Other Non Operating Income (Quarter)
-0.09M0.65M
Non Operating Income (Quarter)
-0.04M-0.05M0.86M-388.00-109.000.01M0.03M0.13M0.19M0.23M0.27M0.31M0.26M0.19M0.15M0.10M0.08M0.22M0.72M
Net income details
EBT (Quarter)
-0.21M-0.40M-22.75M-1.33M-1.56M-1.53M-3.79M-2.49M-3.59M-4.34M-5.15M-5.32M-4.40M-7.14M15.31M-4.53M-6.61M-7.58M-10.68M-10.09M
Tax Provisions (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Profit After Tax (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.28M-5.09M-5.33M-4.41M-7.15M-4.81M-4.54M-6.62M-7.60M-10.65M-10.09M
Income from Non-Controlling Interests (Quarter)
-0.02M-0.02M-0.06M-0.07M-0.07M-0.01M
Income from Continuing Operations (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.34M-5.16M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-10.69M-10.09M
Consolidated Net Income (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.34M-5.16M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-10.69M-10.09M
Income towards Parent Company (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.34M-5.16M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-10.69M-10.09M
Net Income towards Common Stockholders (Quarter)
-0.21M-0.40M-22.76M-1.33M-1.56M-1.54M-3.80M-2.50M-3.60M-4.34M-5.16M-5.33M-4.41M-7.15M15.30M-4.54M-6.62M-7.59M-10.69M-10.09M
Additional items
EPS (Basic) (Quarter)
-0.06-0.12-6.16-0.10-0.11-0.11-0.27-0.18-0.24-0.23-0.24-0.22-0.15-0.24-0.16-0.15-0.22-0.24-0.28-0.18
EPS (Weighted Average and Diluted) (Quarter)
-0.11-0.11-0.27-0.18-0.24-0.23-0.24-0.22-0.15-0.24-0.16-0.15-0.22-0.24-0.28-0.18
Shares Outstanding (Weighted Average) (Quarter)
3.38M3.38M3.67M13.83M13.88M13.88M13.89M13.90M15.04M18.58M17.34M23.44M27.07M27.86M28.29M29.70M29.98M31.93M32.97M55.37M
Shares Outstanding (Diluted Average) (Quarter)
13.86M13.92M13.89M13.90M14.47M18.58M17.34M23.44M27.07M29.42M28.29M29.70M29.98M31.93M32.97M55.37M
EBITDA (Quarter)
-0.20M-0.41M-22.75M-1.32M-1.60M-1.58M-3.77M-2.48M-3.58M-4.31M-5.00M-5.30M-4.37M-7.07M-5.01M-4.53M-6.57M-7.59M-10.69M-10.04M
Interest Expenses (Quarter)
0.05M0.05M0.04M388.00109.00
Shares Outstanding (Quarter)
3.38M3.38M13.23M13.86M-0.04M13.96M13.96M0.03M16.33M19.68M19.99M26.47M27.50M27.55M27.61M27.92M28.48M33.11M52.95M53.08M
Tax Rate (Quarter)
-0.78-0.33-0.01-0.12-0.11-0.11-0.14-0.21-0.18-0.16-0.16-0.17-0.23-0.160.07-0.22-0.13-0.10-0.11